These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27398631)

  • 1. FTIR assay method for UV inactive drug carisoprodol and identification of degradants by RP-HPLC and ESI-MS.
    Acharya PC; Vasi R; Suares D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():16-21. PubMed ID: 27398631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of carisoprodol and meprobamate in oral fluid.
    Coulter C; Garnier M; Tuyay J; Orbita J; Moore C
    J Anal Toxicol; 2012 Apr; 36(3):217-20. PubMed ID: 22417839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validated stability indicating RP-HPLC for quantitation of nitazoxanide in presence of its alkaline degradation products and their characterization by HPLC-tandem mass spectrometry.
    Hegazy M; Kessiba A; El Gindy AE; Abdelkawy M
    J Chromatogr Sci; 2014 Oct; 52(9):1071-81. PubMed ID: 24248557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method.
    Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P
    J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP-HPLC separation and ESI-MS, 1H, and 13C NMR characterization of forced degradants including process related impurities of carisbamate: method development and validation.
    Rao RN; Ramakrishna K; Sravan B; Santhakumar K
    J Pharm Biomed Anal; 2013 Apr; 77():49-54. PubMed ID: 23376724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of carisoprodol and aspirin in human plasma using liquid chromatography-tandem mass spectrometry in polarity switch mode: application to a human pharmacokinetic study.
    Sreenivasulu V; Ramesh M; Kumar IJ; Babu RV; Pilli NR; Krishnaiah A
    Biomed Chromatogr; 2013 Feb; 27(2):179-85. PubMed ID: 22674769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
    Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
    J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FT-IR method development and validation for quantitative estimation of zidovudine in bulk and tablet dosage form.
    Bansal R; Guleria A; Acharya PC
    Drug Res (Stuttg); 2013 Apr; 63(4):165-70. PubMed ID: 23471701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of monoterpene glycosides extracted from Paeonia lactiflora Pall. using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Dong H; Liu Z; Song F; Yu Z; Li H; Liu S
    Rapid Commun Mass Spectrom; 2007; 21(19):3193-9. PubMed ID: 17764105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.